ARTICLE | Company News
Lupin sales and marketing update
February 2, 2015 8:00 AM UTC
Lupin’s Lupin Pharmaceuticals Inc. subsidiary launched an authorized generic of pain drug Celebrex celecoxib in the U.S. in 50, 100, 200 and 400 mg strengths. Lupin has rights from Pfizer Inc. (NYSE...